åæ¥æ®µéã®äŒæ¥ã§ãã Adaptive Biotechnologies Corporation ã¯ãããŸããŸãªçŸæ£ã®èšºæãšæ²»çã®ããã®å
ç«å»çãã©ãããã©ãŒã ãéçºããŠããŸããå瀟ã¯ããã©ã³ã¹ã¬ãŒã·ã§ãã« ãªãµãŒãã®è³ªåãžã®åçãæ°ããäºåŸããã³èšºæã·ã°ãã«ã®çºèŠã«äœ¿çšãããimmunoSEQ ç ç©¶ãµãŒãã¹ãšããããããã³éå»ã® COVID-19 ææã®ç¢ºèªçšã® T-Detect COVID ãæäŸããŠããŸãããŸããç¹å®ã®è¡æ¶²ããæ£è
ã®åŸ®å°æ®åç
å€ã®æ€åºãšã¢ãã¿ãªã³ã°ã«äœ¿çšããå
ç«ã·ãŒã¯ãšã³ã·ã³ã° ãµãŒãã¹ãå«ã clonoSEQ 蚺æãã¹ããããã³ã¯ã¯ãã³éçºè
ãšç ç©¶è
ãã¯ã¯ãã³ã«å¯Ÿãã T 现èå
ç«å¿çãæž¬å®ããããã®immunoSEQ T-MAP COVID ãæäŸããŠããŸããããã«ãå瀟ã¯ããããèªå·±å
ç«çŸæ£ãææçãªã©ã®çŸæ£ã®èšºæãã¢ãã¿ãªã³ã°ãæ²»çã«äœ¿çšãããèšåºè£œåãšãµãŒãã¹ã®ãã€ãã©ã€ã³ãæäŸããŠããŸããå瀟ã¯ãã©ã€ã ãµã€ãšã³ã¹ç ç©¶ãèšåºèšºæãããã³åµè¬ã®é¡§å®¢ã«ãµãŒãã¹ãæäŸããŠããŸãã Adaptive Biotechnologies Corporation ã¯ãããŸããŸãªçã®æ²»çã®ããã®æ°æåèªå° T 现èçæ³ã®éçºã補é ãåååã«é¢ã㊠Genentech, Inc. ãšããŸã 1 åã®è¡æ¶²æ€æ»ã§ããŸããŸãªçŸæ£ãæ©æçºèŠããããã®èšºææ€æ»ã®éçºã«é¢ã㊠Microsoft Corporation ãšæŠç¥çææºãçµãã§ããŸãããŸããèšåºè©Šéšãžã®æ£è
ã®åå ãä¿é²ããããã« Curebase, Inc. ãšå
±åç ç©¶ãè¡ã£ãŠããŸããå瀟ã¯ä»¥å㯠Adaptive TCR Corporation ãšããŠç¥ãããŠããŸãããã2011 幎 12 æã« Adaptive Biotechnologies Corporation ã«ç€Ÿåã倿ŽããŸãããAdaptive Biotechnologies Corporation 㯠2009 幎ã«èšç«ãããã¯ã·ã³ãã³å·ã·ã¢ãã«ã«æ¬ç€Ÿã眮ããŠããŸãã